Target intelligence / Profile preview

Probable UDP-sugar transporter protein SLC35A4 (SLC35A4)

Target
SLC35A4
Molecular classification
Transporter, Solute carrier family (SLC), Nucleotide sugar transporter family
01

Overview

SLC35A4 is a member of the solute carrier family 35 of nucleotide sugar transporters, localized to intracellular organelles such as the Golgi and the mitochondrial inner membrane[1][4][5]. It is predicted to function as a transporter, facilitating the import of CDP-ribitol across organellar membranes, and is notably required for maintaining cellular respiration and for the regulation of protein translation in response to stress[1][4][5]. It does not transport CMP-sialic acid, UDP-galactose, or UDP-N-acetylglucosamine[5][6]. Gene mutations have been implicated in severe neurodevelopmental disorders known as developmental and epileptic encephalopathies[1]. SLC35A4 belongs to a large family of nucleotide sugar transporters, which are essential for glycoprotein and glycolipid biosynthesis[2]. There are no currently known drugs targeting this transporter, and its implication in disease is primarily through loss-of-function mutations.

Other names
Solute carrier family 35 member A4SLC35A4 microproteinSLC35A4-MPSLC35A4 upstream open reading frame proteinSolute carrier family 35 (UDP-galactose transporter), member A4Solute carrier family 35, member A4Tumor rejection antigen
02

Mechanism of action

Not established for therapeutic agents; protein mediates cellular uptake of CDP-ribitol into intracellular compartments

03

Biological functions

Transmembrane transport of nucleotide sugarsPositive regulation of cellular respirationPositive regulation of translation in response to stress
04

Disease associations

Developmental and epileptic encephalopathy (types 15 and 36)Other (rare genetic disorders)
05

Safety considerations

Insufficient information available regarding drug targeting; safety concerns not established
06

Interacting drugs

None currently documented
07

Biomarkers

No established biomarkers for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Probable UDP-sugar transporter protein SLC35A4 (SLC35A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable UDP-sugar transporter protein SLC35A4 (SLC35A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call